Literature DB >> 7447531

Opsonic glycoprotein (plasma fibronectin) levels after burn injury. Relationship to extent of burn and development of sepsis.

M E Lanser, T M Saba, W A Scovill.   

Abstract

The time course of immunoreactive and bioassayable opsonic alpha 2-SB glycoprotein (plasma fibronectin), as well as its relationship to both the extent of injury and development of postburn sepsis, was evaluated following burn injury. Immunoreactive opsonic fibronectin was depleted acutely within hours following burn; its maximal depletion occurring 12 hours postburn injury. The magnitude of depletion was correlated with the body surface area burned, and normal levels were restored at 24 hours postinjury. There was a tendency toward rebound hyperopsonemia at two weeks postburn, with a slow return to normal over the ensuing weeks. Bioassayable opsonic protein levels, in general, paralleled those of immunoreactive protein. Following restoration of opsonic protein levels, a secondary phase of opsonic fibronectin deficiency (p equal to 0.05) developed in those burn patients that became septic. Moreover, this opsonic fibronectin deficiency actually became apparent prior to the onset of clinical sepsis, although it was maximal during sepsis. The resolution of the septic episode was associated with the return of plasma opsonic fibronectin levels to normal. The possibility that secondary deficiency in immunoreactive opsonic fibronectin may be a reliable index of impending sepsis following burn warrants further investigation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7447531      PMCID: PMC1344979          DOI: 10.1097/00000658-198012000-00014

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  27 in total

1.  Resistance to infection in burned patients.

Authors:  H H BALCH
Journal:  Ann Surg       Date:  1963-01       Impact factor: 12.969

2.  Disturbances in the reticulo-endothelial system following thermal injury.

Authors:  G F WARNER; E L DOBSON
Journal:  Am J Physiol       Date:  1954-10

3.  An affinity method for the rapid purification of opsonic alpha 2 SB glycoprotein from serum.

Authors:  F A Blumenstock; T M Saba; P Weber
Journal:  Adv Shock Res       Date:  1979

4.  Differentiated reticuloendothelial system (res) function in some critical surgical conditions.

Authors:  B Schildt; I Gertz; L Wide
Journal:  Acta Chir Scand       Date:  1974

5.  Purification of alpha-2-opsonic protein from human serum and its measurement by immunoassay.

Authors:  F A Blumenstock; T M Saba; P Weber
Journal:  J Reticuloendothel Soc       Date:  1978-02

6.  Deficiency of plasma humoral recognition factor activity following burn injury.

Authors:  A S Goldman; H B Rudloff; R McNamee; L D Loose; N R DiLuzio
Journal:  J Reticuloendothel Soc       Date:  1974-03

7.  Pathophysiology of the respiratory distress syndrome.

Authors:  F W Blaisdell
Journal:  Arch Surg       Date:  1974-01

8.  Effect of burning on hepatic phagocytosis as studied in vitro.

Authors:  B E Schildt; R Bouveng
Journal:  Life Sci I       Date:  1971-04-01

9.  Alterations of the immune response following severe thermal injury.

Authors:  J W Alexander; J A Moncrief
Journal:  Arch Surg       Date:  1966-07

10.  Cryoprecipitate reversal of opsonic alpha2-surface binding glycoprotein deficiency in septic surgical and trauma patients.

Authors:  T M Saba; F A Blumenstock; W A Scovill; H Bernard
Journal:  Science       Date:  1978-08-18       Impact factor: 47.728

View more
  31 in total

1.  Plasma fibronectin concentrations in blood products.

Authors:  J Perttilä; M Salo; O Peltola
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

2.  Fibronectin in neoplastic peritoneal effusions in dogs.

Authors:  B F Feldman; E Brummerstedt; L S Larsen; S Larsen
Journal:  Acta Vet Scand       Date:  1988       Impact factor: 1.695

Review 3.  Plasma fibronectin: relevance for anesthesiology and intensive care.

Authors:  J E Doran; P Lundsgaard-Hansen; E Rubli
Journal:  Intensive Care Med       Date:  1986       Impact factor: 17.440

Review 4.  Fibronectin and the critically ill patient: current status.

Authors:  T M Saba; J L Kiener; J M Holman
Journal:  Intensive Care Med       Date:  1986       Impact factor: 17.440

5.  Plasma fibronectin concentrations in patients with HIV infection and visceral leishmaniasis.

Authors:  A Rodríguez-Cuartero; J Nuñez-Carrill; A Salas-Galán; M A Rodríguez-Rodríguez
Journal:  Infection       Date:  1993 Sep-Oct       Impact factor: 3.553

6.  Implications for collagen binding from the crystallographic structure of fibronectin 6FnI1-2FnII7FnI.

Authors:  Michèle C Erat; Ulrich Schwarz-Linek; Andrew R Pickford; Richard W Farndale; Iain D Campbell; Ioannis Vakonakis
Journal:  J Biol Chem       Date:  2010-08-24       Impact factor: 5.157

7.  Mechanism of acute depletion of plasma fibronectin following thermal injury in rats. Appearance of a gelatinlike ligand in plasma.

Authors:  D C Deno; M H McCafferty; T M Saba; F A Blumenstock
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

8.  Lung vascular permeability after reversal of fibronectin deficiency in septic sheep. Correlation with patient studies.

Authors:  T M Saba; G D Niehaus; W A Scovill; F A Blumenstock; J C Newell; J Holman; S R Powers
Journal:  Ann Surg       Date:  1983-11       Impact factor: 12.969

9.  Opsonic activity of blister fluid from burn patients.

Authors:  E A Deitch
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

10.  Fibronectin in blood products--an in vitro and in vivo study.

Authors:  J T Reilly; B A McVerry; M J Mackie
Journal:  J Clin Pathol       Date:  1983-12       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.